University of California Berkeley:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of California Berkeley - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8088
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and transgender studies, letters and science, liberal arts, linguistics, logic and the methodology of sciencebiophysics, biostatistics, buddhist studies, cognitive science, development practice, integrative biology, interdisciplinary studies, Jewish studies program, mathematics, and others. It carries out research in partnership with academic departments, institutes and centers, museums, and field stations. The university provides educational services through its colleges and schools. UC Berkeley is headquartered in Berkeley, California, the US.

University of California Berkeley – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of California Berkeley, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 10
Novartis Enters into Agreement with University of California 11
University of California, Berkeley Enters into Agreement with Aduro Biotech 12
Licensing Agreements 13
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13
Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 14
Aduro BioTech Enters Into Licensing Agreement With University Of California, Berkeley 15
Aduro BioTech Enters into Licensing Agreement with UCB 16
University of California Berkeley – Key Competitors 17
University of California Berkeley – Key Employees 18
University of California Berkeley – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Sep 26, 2018: CZ Biohub awards $13.7 million for new collaborative health research 20
Aug 16, 2018: New Approach to Fight Tuberculosis, a Leading Cause of Death Worldwide 21
Aug 02, 2018: Obesity extends duration of influenza a virus shedding 23
Jul 18, 2018: St. Baldrick’s foundation announces $19.1 million in grants to fund lifesaving childhood cancer research 24
May 14, 2018: New structure of tau protein, a key player in Alzheimer’s disease 25
Jan 29, 2018: Kenneth Rainin Foundation: $1.7 Million to Improve IBD Patient Outcomes 26
Jan 23, 2018: Damon Runyon Cancer Research Foundation awards $3M to eleven innovative early career scientists 27
Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 30
Jul 19, 2017: UC Berkeley: Defense department pours $65 million into making CRISPR safer 32
Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 34
Jul 12, 2017: Anti-CRISPR proteins decrease off-target side effects of CRISPR-Cas9 37
Jan 13, 2017: Scientists reprogram embryonic stem cells to expand their potential cell fates 39
Product News 41
Apr 11, 2018: New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
University of California Berkeley, Pharmaceuticals & Healthcare, Key Facts 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of California Berkeley, Deals By Therapy Area, 2012 to YTD 2018 8
University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 10
Novartis Enters into Agreement with University of California 11
University of California, Berkeley Enters into Agreement with Aduro Biotech 12
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13
Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 14
Aduro BioTech Enters Into Licensing Agreement With University Of California, Berkeley 15
Aduro BioTech Enters into Licensing Agreement with UCB 16
University of California Berkeley, Key Competitors 17
University of California Berkeley, Key Employees 18
University of California Berkeley, Subsidiaries 19

List of Figures
University of California Berkeley, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of California Berkeley, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[University of California Berkeley:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Poslovni sistem Mercator, d.d.:企業の戦略・SWOT・財務情報
    Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report Summary Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Anthem, Inc.:企業のM&A・事業提携・投資動向
    Anthem, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthem, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Trivitron Healthcare Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Trivitron Healthcare Pvt Ltd (Trivitron) is a medical technology company that provides solutions to healthcare providers. The company’s products include radiography and c-arm systems, newborn screening, mammography, ultrasound, contrast media, breast biopsy system, bone densitometer, radiati …
  • Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析
    Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BioDiem Ltd:企業の戦略的SWOT分析
    BioDiem Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • PT Elnusa Tbk (ELSA):企業の財務・戦略的SWOT分析
    Summary PT Elnusa Tbk (PT Elnusa), a subsidiary of PT Pertamina (Persero), is an oil and gas company that offers geo science services, and drilling and oilfield services. The company's geo science services include seismic data acquisition, seismic data measurement, seismic data processing, and non s …
  • Sabre Corp (SABR):企業の財務・戦略的SWOT分析
    Sabre Corp (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • China Minsheng Banking Corp Ltd:企業の戦略・SWOT・財務情報
    China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Copper Mountain Mining Corporation:企業の戦略・SWOT・財務情報
    Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Penske Automotive Group, Inc.:企業の戦略・SWOT・財務情報
    Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • InnaVirVax SA-製薬・医療分野:企業M&A・提携分析
    Summary InnaVirVax SA (InnaVirVax) is a biopharmaceutical company which discovers and develops products for the treatment of HIV/AIDS infection pathologically and novel cancer therapies. The company's pipeline product portfolio comprise DIAG-3S, an AIDS prognostic test; VAC-3S, an HIV AIDs therapeut …
  • ViraTherapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ViraTherapeutics GmbH (ViraTherapeutics) is a biotechnology company that develops high potential anti-cancer therapeutics based on cancer-destroying oncolytic viruses. The company provides VSV-GP which is a proprietary oncolytic virus platform, which helps in destroying cancer cells and is u …
  • Prolung Inc (LUNG):医療機器:M&Aディール及び事業提携情報
    Summary Prolung Inc(Prolung) formerly known as Fresh Medical Laboratories Inc, is a medical device company that offers diagnostic services. The company offers electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists o …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Pakistan Services Ltd.
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wacker Chemie AG (WCH):企業の財務・戦略的SWOT分析
    Wacker Chemie AG (WCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Anek Lines SA:企業の戦略・SWOT・財務情報
    Anek Lines SA - Strategy, SWOT and Corporate Finance Report Summary Anek Lines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆